Merck also sells an antibiotic called Zerbaxa (ceftolozane and tazobactam) for cUTI and cIAI, that it acquired along with Cubist Pharma almost six years ago in a $9.5 billion deal. A landmark ...

U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that ...

Among them are: Keytruda, Merck’s cancer drug ... as well as key antibiotics and antivirals, had no American facility producing their active ingredients, according to Clarivate.

Standardized aluminum oxide 90 supplied by Merck (Darmstadt, Germany ... All solutions were stored at −20 °C before use. Minimal essential medium (1× MEM and 10× MEM), fetal bovine serum (FBS), ...

The medium was supplemented with 1 M dexamethasone (Merck, Darmstadt, Germany), 0.2 mM isobutyl ... containing 2 ml of DMEM supplemented with 10% fetal bovine serum and antibiotics (penicillin and ...

Antibiotics are commonly prescribed to young children to combat conditions such as ear infections and pneumonia. But the drugs may disrupt the digestive microbiome at a significant time in a child’s ...

Delayed initiation of broad-spectrum gram-negative antibiotic therapy was not linked to worse clinical outcomes among adult inpatients.

A research team led by Professor Tong Zhang from the Department of Civil Engineering of Faculty of Engineering at the ...

Merck & Co/MSD’s three-drug antibiotic Recarbrio has been recommended for approval in Europe for Gram-negative infections, but should be reserved for use in patients with limited treatment options.

Analysts' ratings for Merck & Co MRK over the last quarter vary from bullish to bearish, as provided by 9 analysts. The table below provides a snapshot of their recent ratings, showcasing how ...